https://drugnews.com.tw/articles/2026-08-22-revolution-medicines-beone-four-ras-programs-en.html Drugnews｜藥時事 en 2026-08-22T00:00:00.000Z BeOne Bets on Four RAS Drugs: The Real Asset Is Development Optionality https://drugnews.com.tw/articles/2026-08-22-revolution-medicines-beone-four-ras-programs.html Drugnews｜藥時事 zh-tw 2026-08-22T00:00:00.000Z 百濟神州一口氣押上 4 款 RAS 新藥 https://drugnews.com.tw/articles/2026-08-21-moderna-merck-intismeran-phase3-melanoma-en.html Drugnews｜藥時事 en 2026-08-21T00:00:00.000Z Moderna Surges 176.97% After Its Personalized Cancer Vaccine Clears a Phase 3 Test https://drugnews.com.tw/articles/2026-08-21-moderna-merck-intismeran-phase3-melanoma.html Drugnews｜藥時事 zh-tw 2026-08-21T00:00:00.000Z 再見癌症？癌症疫苗來了！莫德納單日暴漲176.97%